Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H.
Transplantation Proceedings 28(6): 3348-3350
1996
ISSN/ISBN: 0041-1345 PMID: 8962302 Document Number: 456395
Document emailed within 1 workday
Related Documents
Dotti, G.; Gaspari, F.; Caruso, R.; Perico, N.; Remuzzi, G.; Barbui, T.; Rambaldi, A. 2001: Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients Haematologica 86(3): 311-315Hauters, P.; de Hemptinne, B.; Carlier, M.; Malaise, J.; Ottobrelli, A.; Delaby, J.; Balducci, G.; Kestens, P.J.; Otte, J.B. 1991: Long-term analysis of glomerular filtration rate and hypertension in adult liver transplant recipients treated with cyclosporine a Transplantation Proceedings 23(1 Part 2): 1458-1459
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Radovancevic, B.; Birovljev, S.; Frazier, O.H.; Duncan, J.M.; Bennink, W.; Sweeney, M.S.; McAllister, H.A.; Burnett, C.M.; Vega, J.D.; Lonquist, J.L. 1990: Long-term follow-up of cyclosporine-treated cardiac transplant recipients Transplantation Proceedings 22(3 Suppl 1): 21-24
Winkler, M.; Haller, G.; Oldhafer, K.; Bechstein, W.O.; Kattner, A.; Maibücher, A.; Färber, L.; Ringe, B.; Christians, U.; Neuhaus, P.; Pichlmayr, R. 1996: A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients Transplantation 62(8): 1063-1068
Diflo, T.; Maki, T.; Monaco, A.P. 1989: Long-term survival and tolerance in allogeneic rat small bowel transplant recipients treated with cyclosporine Transplantation Proceedings 21(1 Pt 3): 2885-2886
Salomon, D.R. 1991: An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients Transplantation Proceedings 23(4): 2115-2118
Levy, G.A. 1996: Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral Transplantation Proceedings 28(4): 2252-2253
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Remberger, M.; Ringden, O.; Aschan, J.; Ljungman, P.; Lönnqvist, B.; Markling, L. 1994: Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients Transplantation Proceedings 26(3): 1829-1830
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
Hughes, J.R.; Hughes, V.F.; Trull, A.K.; Metcalfe, S.M. 1999: Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine Transplantation 68(4): 583-586
Romagnoli, J.; Baiocchi, L.; Tisone, G.; Angelico, M.; Pisani, F.; Negrini, S.; Iaria, G.; Nistri, A.; Casciani, C.U. 1996: Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients Transplantation Proceedings 28(6): 3129-3130
Tredger, J.M.; Steward, C.M.; Williams, R. 1988: Blood cyclosporine concentrations in liver transplant recipients: assay method and influence of changed hepatic and renal function Transplantation Proceedings 20(3 Suppl 3: 391-393
Mihatsch, M.J.; Morozumi, K.; Strøm, E.H.; Ryffel, B.; Gudat, F.; Thiel, G. 1995: Renal transplant morphology after long-term therapy with cyclosporine Transplantation Proceedings 27(1): 39-42
Sadek, S.; Medina, Jé.; Arias, M.; Sennesael, J.; Squifflet, J-Paul.; Vogt, B. 2002: Short-term combination of mycophenolate mofetil with cyclosporine as a therapeutic option for renal transplant recipients: A prospective, multicenter, randomized study Transplantation 74(4): 511-517
Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375
Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Lorber, M.I.; Barker, C.J.; Golden, D.L.; Kahan, B.D. 1986: Long-term results of cyclosporine therapy in recipients of mismatched living related kidneys Transplantation Proceedings 18(2 Suppl 1): 44-51
Trull, A.; Hue, K.; Tan, K.; Gore, S.; Whitewood, S.; Smyth, R.; Scott, J.; Price, C.; Wallwork, J. 1990: Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients Clinical Chemistry 36(8 Part 1): 1474-1478